Kuria Therapeutics to Present at 2023 Ophthalmology Futures Retina Forum
- Kuria's Chief Executive Officer Dr. Keith Ward to discuss preclinical proof-of-concept data in dry AMD and Kuria's development plans...
Kuria will initiate 3 clinical programs, with 2 product candidates, within 12 months from funding.
View our CEO's company presentation for the 2023 Ophthalmology Futures European Forum (Vienna, Austria)